Acta Scientific Cancer Biology

Case ReportVolume 1 Issue 1

Pathogenesis and Management Strategy for Docetaxel Induced Facial Nerve Paralysis

Shekhar Gogna*

Resident General Surgery, Westchester Medical Center, Valhalla, New York, USA

*Corresponding Author: Shekhar Gogna, Resident General Surgery, Westchester Medical Center, Valhalla, New York, USA.

Received: May 22, 2017; Published: July 17, 2017

Citation: Shekhar Gogna. “Pathogenesis and Management Strategy for Docetaxel Induced Facial Nerve Paralysis”. Acta Scientific Cancer Biology 1.1 (2018).

Abstract

  Docetaxel is used as first line chemotherapy in head and squamous cell cancer. Peripheral sensory/motor neuropathy is a well- known side effect of docetaxel. We want to present a case of reversible docetaxel induced unilateral peripheral facial nerve palsy to identify this unique side effect.

Keywords: Docetaxel; Facial Nerve Palsy; Pathology; Management

Copyright: © 2018 Shekhar Gogna. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Member In



News and Events


  • Submission Timeline for Regular Issue
    The last date for submission of articles for regular Issues is November 30, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US